185 related articles for article (PubMed ID: 12753309)
1. Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients.
Ferraro B; Galli F; Frei B; Kingdon E; Canestrari F; Rice-Evans C; Buoncristiani U; Davenport A; Moore KP
Kidney Int; 2003 Jun; 63(6):2207-13. PubMed ID: 12753309
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.
Handelman GJ; Walter MF; Adhikarla R; Gross J; Dallal GE; Levin NW; Blumberg JB
Kidney Int; 2001 May; 59(5):1960-6. PubMed ID: 11318969
[TBL] [Abstract][Full Text] [Related]
3. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
[TBL] [Abstract][Full Text] [Related]
4. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite.
Moore KP; Darley-Usmar V; Morrow J; Roberts LJ
Circ Res; 1995 Aug; 77(2):335-41. PubMed ID: 7614720
[TBL] [Abstract][Full Text] [Related]
5. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis.
Salahudeen AK; Oliver B; Bower JD; Roberts LJ
Kidney Int; 2001 Oct; 60(4):1525-31. PubMed ID: 11576368
[TBL] [Abstract][Full Text] [Related]
6. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
Ikizler TA; Morrow JD; Roberts LJ; Evanson JA; Becker B; Hakim RM; Shyr Y; Himmelfarb J
Clin Nephrol; 2002 Sep; 58(3):190-7. PubMed ID: 12356187
[TBL] [Abstract][Full Text] [Related]
7. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.
Rivara MB; Ikizler TA; Ellis CD; Mehrotra R; Himmelfarb J
BMC Nephrol; 2015 Jun; 16():79. PubMed ID: 26045064
[TBL] [Abstract][Full Text] [Related]
8. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients.
Lim PS; Chang YM; Thien LM; Wang NP; Yang CC; Chen TT; Hsu WM
Blood Purif; 2002; 20(6):537-42. PubMed ID: 12566669
[TBL] [Abstract][Full Text] [Related]
9. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.
Thomas SR; Davies MJ; Stocker R
Chem Res Toxicol; 1998 May; 11(5):484-94. PubMed ID: 9585479
[TBL] [Abstract][Full Text] [Related]
10. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids.
van der Veen RC; Roberts LJ
J Neuroimmunol; 1999 Mar; 95(1-2):1-7. PubMed ID: 10229110
[TBL] [Abstract][Full Text] [Related]
11. Effect of Coenzyme Q
Rivara MB; Yeung CK; Robinson-Cohen C; Phillips BR; Ruzinski J; Rock D; Linke L; Shen DD; Ikizler TA; Himmelfarb J
Am J Kidney Dis; 2017 Mar; 69(3):389-399. PubMed ID: 27927588
[TBL] [Abstract][Full Text] [Related]
12. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure.
Wiswedel I; Hirsch D; Carluccio F; Hampl H; Siems W
Biofactors; 2005; 24(1-4):201-8. PubMed ID: 16403981
[TBL] [Abstract][Full Text] [Related]
13. Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress.
Klings ES; Christman BW; McClung J; Stucchi AF; McMahon L; Brauer M; Farber HW
Am J Respir Crit Care Med; 2001 Oct; 164(7):1248-52. PubMed ID: 11673218
[TBL] [Abstract][Full Text] [Related]
14. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
Conner TA; McQuade C; Olp J; Pai AB
Biometals; 2012 Oct; 25(5):961-9. PubMed ID: 22706571
[TBL] [Abstract][Full Text] [Related]
16. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
Schweer H; Watzer B; Seyberth HW; Nüsing RM
J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
[TBL] [Abstract][Full Text] [Related]
17. Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water.
Huang KC; Yang CC; Lee KT; Chien CT
Kidney Int; 2003 Aug; 64(2):704-14. PubMed ID: 12846769
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis decreases serum brain-derived neurotrophic factor concentration in humans.
Zoladz JA; Śmigielski M; Majerczak J; Nowak ŁR; Zapart-Bukowska J; Smoleński O; Kulpa J; Duda K; Drzewińska J; Bartosz G
Neurochem Res; 2012 Dec; 37(12):2715-24. PubMed ID: 22903469
[TBL] [Abstract][Full Text] [Related]
19. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
Mori TA; Croft KD; Puddey IB; Beilin LJ
Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
[TBL] [Abstract][Full Text] [Related]
20. Optimized method for quantification of total F(2)-isoprostanes using gas chromatography-tandem mass spectrometry.
Briskey DR; Wilson GR; Fassett RG; Coombes JS
J Pharm Biomed Anal; 2014 Mar; 90():161-6. PubMed ID: 24378611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
